Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chitin synthase 1 (CHS1) is the key enzyme within the chitin synthesis machinery of ectoparasites such as the cat flea, Ctenocephalides felis (UniProt, https://www.uniprot.org/uniprotkb/Q9GNY0/entry). It is responsible for the polymerization of N-acetylglucosamine into chitin, which provides structural integrity to the insect's exoskeleton and the protective shell of its eggs (NCBI, https://pubmed.ncbi.nlm.nih.gov/8829700/). In the life cycle of the flea, this machinery is particularly vital during embryogenesis and the molting of larvae, where rapid chitin deposition is required. Drugs like lufenuron target this process by inhibiting the synthesis and assembly of chitin fibers, leading to eggs that fail to hatch and larvae that cannot survive the transition to the next developmental stage (PubChem, https://pubchem.ncbi.nlm.nih.gov/compound/Lufenuron). Because chitin is absent in vertebrate biology, CHS1 serves as a highly selective target for veterinary ectoparasiticides with minimal risk to the host (VCA Animal Hospitals, https://vcahospitals.com/know-your-pet/flea-control-lufenuron). However, these agents are typically not adulticidal, meaning they control flea populations by breaking the reproductive cycle rather than killing existing adult fleas on the animal. This mechanism is essential for long-term management of infestations and the prevention of flea-associated conditions like flea allergy dermatitis. The specificity of this target ensures that the drugs do not interfere with the metabolic processes of the treated pets.
Inhibition of chitin polymerization and deposition during cuticle and eggshell formation (PubChem, https://pubchem.ncbi.nlm.nih.gov/compound/Lufenuron; ScienceDirect, https://www.sciencedirect.com/topics/agricultural-and-biological-sciences/chitin-synthesis-inhibitor)
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chitin synthase 1 (CHS1) (CHS1).